0.9200EUR-16.36%Mkt Cap: 17.99M EURP/E: —Last update: 2026-05-14
Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally. The company develops and markets IVDs in the form of RDTs and TRODs, immun…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)2.12
PEG—
P/B0.38
P/S0.16
EV/EBITDA—
EV/Revenue—
EPS (TTM)-4.03
EPS (Forward)0.46
Cash Flow & Leverage
FCF Yield48.83%
FCF Margin7.63%
Operating CF-10.12M EUR
CapEx (TTM)4.84M EUR
Net Debt/EBITDA9.48
Net Debt53.19M EUR
Technical
SMA 500.8684 (+5.9%)
SMA 2000.8320 (+10.6%)
Beta—
S&P 52W Chg24.23%
Avg Vol (30d)76.33K
Avg Vol (10d)234.43K
Technical Indicators
RSI (14)49.3
MACD0.0735
MACD Signal0.0443
MACD Hist.+0.0292
BB Upper1.319 EUR
BB Middle0.9153 EUR
BB Lower0.5116 EUR
BB Width88.22%
ATR (14)0.1716 EUR
Vol Ratio (20d)1.15x
52W Range
0.455041% of range1.590
52W High1.590 EUR
52W Low0.4550 EUR
Profitability
Gross Margin56.76%
EBITDA Margin4.87%
Profit Margin-42.83%
Oper. Margin-20.93%
ROE-53.78%
ROA-22.26%
Revenue Growth-8.00%
Earnings Growth—
Balance Sheet
Debt/Equity0.78
Current Ratio3.24
Quick Ratio1.91
Book Value/Sh2.563 EUR
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateMay 16, 2022
Pay Date—
Ownership
Shares Out.18.43M
Float—
Insiders57.60%
Institutions0.00%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap17.99M EUR
Enterprise Value—
Revenue (TTM)115.13M EUR
Gross Profit57.42M EUR
Net Income (TTM)-43.33M EUR
Revenue/Share—
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
Last Price0.9200 EUR
CountryFR
SectorHealthcare
IndustryMedical Devices
ISINFR0011005933